Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS)
$0.8399 -0.00 (-0.01%)
Analysed Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) News Sources
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln
Reuters
Sino Biopharma and Sanofi reach over $1.5 billion BD transaction
China Daily Global Edition
Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset
Fierce Pharma
Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit
Seeking Alpha
Sino Biopharm Licenses Rovadicitinib to Sanofi for up to $1.5B
Contract Pharma
Sino Biopharma signs up to $1.4 bln licensing deal with Sanofi
Investing.com India
Sanofi licenses rovadicitinib from Sino Biopharm in up to $1.5 billion deal
The Pharma Letter
Sino Biopharm Inks Up to $1.5 Billion Deal With Sanofi for Cancer Treatment
Morningstar
Sino Biopharm Signs $1.5B Drug License Agreement with Sanofi
Digital Phablet
China clears first JAK/ROCK drug for myelofibrosis
BioWorld
What is the current price of Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS)?
The current price of Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) is $0.8399.
Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) since the previous trading day is $-0.00.
Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) since the previous trading day is -0.01%.
What is This Week's average sentiment score for Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS)?
This Week's average sentiment score for Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) is 78 out of 100.
What is This Week's average sentiment for Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS)?
This Week's sentiment for Sino Biopharmaceutical Ltd (SBMFF:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.